The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: epirubicin, cyclophosphamide, paclitaxel, carboplatin, G-CSF
Sponsor: Chinese Academy of Medical Sciences